Skip to main content
Log in

Bestimmung des C‑reaktiven Proteins zur Therapieentscheidung über Antibiotikagabe bei COPD-Exazerbation

Determination of C-reactive protein for treatment decision on prescription of antibiotics for aggravated COPD

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Zhou Z, Zhou A, Zhao Y, Chen P (2017) Evaluating the Clinical COPD Questionnaire: A systematic review. Respirology 22(2):251–262. https://doi.org/10.1111/resp.12970

    Article  PubMed  Google Scholar 

  2. Miravitlles M, Moragas A, Hernández S, Bayona C, Llor C (2013) Is It Possible to Identify Exacerbations of Mild to Moderate COPD That Do Not Require Antibiotic Treatment? CHEST 144(5):1571–1577. https://doi.org/10.1378/chest.13-0518

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Rembert Koczulla.

Ethics declarations

Interessenkonflikt

A.R. Koczulla gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

J. Schreiber, Magdeburg

P. Zabel, Lübeck/Borstel

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koczulla, A.R. Bestimmung des C‑reaktiven Proteins zur Therapieentscheidung über Antibiotikagabe bei COPD-Exazerbation. Pneumologe 16, 379–380 (2019). https://doi.org/10.1007/s10405-019-00274-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-019-00274-9

Navigation